TEE
NERV icon

Tibra Equities Europe’s Minerva Neurosciences NERV Stock Holding History

Tibra Equities Europe’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,013
Closed -$316K – 141
2021
Q2 		$316K Buy
+17,013
New +$366K 0.1% 158

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tibra Equities Europe's NERV Position: Q3 2021 in Review

Tibra Equities Europe sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 17,013 shares — an estimated $316K sold.

Tibra Equities Europe first reported a position in NERV in Q2 2021 and held it in 1 quarter. The position peaked at $316K in Q2 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Tibra Equities Europe reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 17,013 Minerva Neurosciences shares in Q3 2021, an estimated $316K.
  • Tibra Equities Europe first reported a position in Minerva Neurosciences in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Minerva Neurosciences position peaked at $316K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.